Januvia Tablet, Film Coated
Product Images NDC 50090-4084

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 50090-4084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Januvia 01)

Image Of Sitagliptin Chemical Structure (Januvia 01)
Chemical structure diagram of sitagliptin phosphate monohydrate, the active ingredient in JANUVIA 100 mg oral tablets, depicting its molecular framework including trifluoromethyl and fluorophenyl groups.*
FDA Label Image

Image Of Figure 1 (Januvia 02)

Image Of Figure 1 (Januvia 02)
A line graph depicting LS mean change from baseline over 24 weeks for six treatment groups: placebo, metformin 500 mg b.i.d., metformin 1000 mg b.i.d., sitagliptin 100 mg q.d., sitagliptin 50 mg b.i.d. plus metformin 500 mg b.i.d., and sitagliptin 50 mg b.i.d. plus metformin 1000 mg b.i.d. The y-axis shows LS mean change from baseline; the x-axis shows weeks (0 to 24).*
FDA Label Image

Image Of Figure 2 (Januvia 03)

Image Of Figure 2 (Januvia 03)
A line graph comparing the LS Mean Change from Baseline over 52 weeks between Januvia 100 mg and Glipizide. The x-axis represents the weeks from 0 to 52, and the y-axis shows the LS Mean Change from Baseline ranging approximately from 0 to -1.5. Data points for Januvia 100 mg are marked with diamonds, and Glipizide with circles, depicting similar trends over time.*
FDA Label Image

Label Image (Lbl500904084)

Label Image (Lbl500904084)
Label for JANUVIA 100 mg film-coated tablets containing sitagliptin, from A-S Medication Solutions. It indicates each tablet contains 128 mg sitagliptin phosphate equivalent to 100 mg sitagliptin, with a package count of 90 tablets. Storage instructions specify 68 to 77 degrees Fahrenheit. The label includes a lot number, dispensing instructions, and the labeler address.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.